Baseline clinical and MR imaging characteristics of the study subjects
| Characteristic | Placebo Group (n = 120) | GA Group (n = 119) |
|---|---|---|
| Age (y) | 34.0 ± 7.5 | 34.1 ± 7.4 |
| Disease duration (y) | 8.3 ± 5.5 | 7.9 ± 5.5 |
| Prior 2-year relapse rate | 2.5 ± 1.4 | 2.8 ± 1.8 |
| EDSS score | 2.4 ± 1.2 | 2.3 ± 1.1 |
| No. of Gd-enhancing lesions | 4.4 ± 7.1 | 4.2 ± 4.8 |
| Volume of lesions (cm3) | ||
| Gd enhancing | 0.7 ± 2.2 | 0.6 ± 0.7 |
| Hyperintense on T2-weighted images | 20.5 ± 18.8 | 20.0 ± 17.2 |
| Hypointense on T1-weighted images | 4.0 ± 4.9 | 3.4 ± 3.9 |
Note.—Data are the mean ± SD.